AcuCort enters agreement with the pharmaceutical manufacturer Adhex Pharma regarding commercial and large-scale production of ISICORT®
AcuCort AB (publ) (Spotlight Stock Market: ACUC) announced today that the company has signed an agreement with the contract manufacturing company Adhex Pharma regarding commercial and large-scale production of ISICORT®. This product supply agreement is an important milestone for the upcoming commercialization of ISICORT®.Under the terms of this agreement with the contract manufacturer Adhex Pharma, AcuCort secures the commercial and large-scale production of its drug ISICORT®, and in line with GMP (Good Manufacturing Practice). Thus, by this agreement the product supply of ISICORT® is